Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Numan raises $60m

UK-based digital health company Numan has raised €60 million (~€51 million) of venture funding to continue scaling up its weight loss and men’s health telehealth services.

HBI’s Asia Special Report 2025

In HBI’s Asia Special Report, we explore healthcare investment across eight key markets: China, India, South Korea, Thailand, Vietnam, Indonesia, Malaysia, and the Philippines. 

US-based Merck buys UK’s Verona Pharma for $10bn

Big pharma is investing heavily in late-stage biotech, focusing on approved or near-market treatments in high-need areas like respiratory disease, as companies prepare for future revenue drops from older high-earning medicines.

Interview with Ash Ramachandran, Founder of Sapyen, on the untapped male fertility diagnostics market

Sapyen, an online male fertility diagnostics company based in Melbourne, with operations across the UK, Europe, the US, and Australia, is trying to fix that. The company has developed a home testing kit that extends the viability of semen samples, making it easier for men to get tested without needing to visit a clinic. Ash Ramachandran, the founder of Sapyen, spoke to HBI about the fertility landscape, investment trends, and how the company is helping men access testing more easily.

Romanian Competition Council reviews Mehiläinen’s acquisition of Regina Maria and MediGroup

In April 2025, HBI reported that Mehiläinen, Finland’s largest private healthcare group, backed by Luxembourg-based private equity firm CVC Capital Partners, had bought Romania’s Regina Maria and Serbia’s MediGroup from private equity firm MidEuropa. Now, Romania’s Competition Council has officially opened an investigation to see if the deal might reduce competition in the local healthcare market. This review is an important regulatory step that could affect whether the acquisition is finally approved and under what conditions.

Find Us